VIE - Business Development Coordinator (M/F)

Abolis Biotechnologies SAS; Boston, Northern (MA, KY); Hybrid; USD 33,000 - 47,000; Full time

Job summary

Abolis Biotechnologies SAS in Boston, MA, is launching a VIE position to drive North American growth. You will identify opportunities, build relationships with prospective partners and clients, and help establish Abolis's presence in a leading biotech ecosystem.

Reporting to the Head of Business Development in the US, the VIE will conduct market intelligence, prepare pitches, and maintain CRM records while representing Abolis at trade shows and events in the US.

Qualifications

• Master's degree or equivalent in biotech, engineering, life sciences, or related field.
• International experience (internship/exchange/VIE) is a plus.
• Fluent English required; French is a plus for coordination with teams in France.

Responsibilities

• Identify opportunities and build relationships with prospective partners and clients in North America.
• Support outreach, lead generation, and qualification of prospects across sectors (food, cosmetics, healthcare, specialty chemicals).
• Prepare pitches, proposals, and technical/commercial presentations for prospects and partners.
• Represent Abolis at trade shows, industry conferences, and networking events in the US.
• Maintain and update CRM records; report on pipeline and BD activity.

Skills

Fluent English

French a plus

Strong communication

Autonomy

Organizational skills

Entrepreneurial mindset

Independent work

Startup mindset

Education

Master's degree (Bac+5) in biotech / life sciences

Tools

Office

CRM tools

Job description

As part of our international growth strategy, we are opening a VIE position based in Boston, MA, to support the development of Abolis's business across North America.

Reporting to and working closely with Felipe Sarmiento, our Head of Business Development in the US, the VIE will play a key role in identifying opportunities, building relationships with prospective partners and clients, and helping establish Abolis's presence in one of the world's most dynamic biotech ecosystems.

• Supporting outreach, lead generation, and qualification of prospective clients and industrial partners across the food, cosmetics, healthcare, and specialty chemicals sectors in North America.

• Conducting market and competitive intelligence to identify partnership, licensing, and joint-development opportunities for Abolis's strain engineering platform, as well as M.I.N.E. software solution (previously known as Microbiome Studio).

• Assisting in the preparation of pitch materials, proposals, and technical/commercial presentations for prospects and partners

• Representing Abolis at trade shows, industry conferences, and networking events in the US

• Maintaining and updating CRM records and contributing to regular reporting on pipeline and business development activity

• Master's degree (or equivalent, Bac+5) from a biotech school, engineering school, university program, or life science cursus ideally with a specialization or strong interest a business and commercial development

• Previous international experience (internship, exchange, or prior VIE) is a plus

• Fluent English required; French is a plus for coordination with teams in France

• Comfortable engaging with scientific and technical content, and able to translate it into clear commercial arguments

• Strong communication, autonomy, and organizational skills; comfortable working independently in a small, remote team setup

• Proficiency in Office and CRM tools

• Entrepreneurial mindset, curiosity, and resilience — well suited to a fast-moving startup/scale-up environment

• Eligible for the VIE program: French or other EU/EEA national, aged 22+ at the time of application

Practical Information

• Location: Boston, MA, United States

• Contract type: VIE (Volontariat International en Entreprise), managed by Business France

• Duration: 12 months (possibility 18 months)

• Start date: Q4 2026

• Compensation: Monthly VIE allowance per Business France's official scale for the United States (a "dérogatoire" country with a specific indemnity level), tax-exempt in France, plus full social coverage

• Reporting line: Felipe Sarmiento, Head of BD, Abolis Biotechnologies